Form 4 for MRNA Moderna
Accepted 2025-02-14 00:00:00 ET · period of report 2025-02-12 · accession 0001127602-25-004900 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-14 | 2025-02-12 | MRNA | Hoge Stephen | Pres | A - Grant | $0.00 | +5,734 | 1.45M | +0.4% | $0 | |
| 2025-02-14 | 2025-02-12 | MRNA | Hoge Stephen | Pres | F - Tax | $30.93 | -2,771 | 1.45M | -0.2% | -$85.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-12 | A | A | 5,734 | $0.00 | 1,449,880 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-12 | F | D | 2,771 | $30.93 | 1,447,109 | D | — | — |